Y-Intercept (HK)’s Mesa Laboratories MLAB Stock Holding History

Y-Intercept (HK)’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$996K	Buy	10,010 +3,695	+59%	+$372K	0.02%	1055
2026 Q1	$558K	Buy	+6,315	New	+$544K	0.01%	1234
2023 Q4	–	Sell	-2,071	Closed	-$218K	–	1490
2023 Q3	$218K	Buy	+2,071	New	+$265K	0.02%	889

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Y-Intercept (HK)'s MLAB Position: Q2 2026 in Review

Y-Intercept (HK) increased its Mesa Laboratories (MLAB) stake by 59% in Q2 2026, buying an estimated $372K and bringing the position to 10,010 shares worth $996K. The position accounts for 0.02% of the portfolio, ranked #1055.

Y-Intercept (HK) first reported a position in MLAB in Q3 2023 and has held it in 3 quarters since. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Y-Intercept (HK) held 10,010 shares of Mesa Laboratories worth $996K as of Q2 2026.
Y-Intercept (HK) bought 3,695 Mesa Laboratories shares in Q2 2026, an estimated $372K.
Mesa Laboratories made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1055 holding.
Y-Intercept (HK) first reported a position in Mesa Laboratories in Q3 2023 and has held it in 3 quarters since.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.